These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 29079454)

  • 61. Defective Cytochrome P450-Catalysed Drug Metabolism in Niemann-Pick Type C Disease.
    Nicoli ER; Al Eisa N; Cluzeau CV; Wassif CA; Gray J; Burkert KR; Smith DA; Morris L; Cologna SM; Peer CJ; Sissung TM; Uscatu CD; Figg WD; Pavan WJ; Vite CH; Porter FD; Platt FM
    PLoS One; 2016; 11(3):e0152007. PubMed ID: 27019000
    [TBL] [Abstract][Full Text] [Related]  

  • 62. LC3 Immunostaining in the Inferior Olivary Nuclei of Cats With Niemann-Pick Disease Type C1 Is Associated With Patterned Purkinje Cell Loss.
    Gurda BL; Bagel JH; Fisher SJ; Schultz ML; Lieberman AP; Hand P; Vite CH; Swain GP
    J Neuropathol Exp Neurol; 2018 Mar; 77(3):229-245. PubMed ID: 29346563
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Allopregnanolone treatment, both as a single injection or repetitively, delays demyelination and enhances survival of Niemann-Pick C mice.
    Ahmad I; Lope-Piedrafita S; Bi X; Hicks C; Yao Y; Yu C; Chaitkin E; Howison CM; Weberg L; Trouard TP; Erickson RP
    J Neurosci Res; 2005 Dec; 82(6):811-21. PubMed ID: 16273542
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Gender-Specific Effects of Two Treatment Strategies in a Mouse Model of Niemann-Pick Disease Type C1.
    Holzmann C; Witt M; Rolfs A; Antipova V; Wree A
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33802605
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Activation of the adenosine A2A receptor attenuates experimental autoimmune encephalomyelitis and is associated with increased intracellular calcium levels.
    Liu Y; Zou H; Zhao P; Sun B; Wang J; Kong Q; Mu L; Zhao S; Wang G; Wang D; Zhang Y; Zhao J; Yin P; Liu L; Zhao X; Li H
    Neuroscience; 2016 Aug; 330():150-61. PubMed ID: 27217214
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Abnormal LAMP1 glycosylation may play a role in Niemann-Pick disease, type C pathology.
    Cawley NX; Sojka C; Cougnoux A; Lyons AT; Nicoli ER; Wassif CA; Porter FD
    PLoS One; 2020; 15(1):e0227829. PubMed ID: 31999726
    [TBL] [Abstract][Full Text] [Related]  

  • 67. In Vitro and In Vivo Evaluation of 6-O-α-Maltosyl-β-Cyclodextrin as a Potential Therapeutic Agent Against Niemann-Pick Disease Type C.
    Yasmin N; Ishitsuka Y; Fukaura M; Yamada Y; Nakahara S; Ishii A; Kondo Y; Takeo T; Nakagata N; Motoyama K; Higashi T; Okada Y; Nishikawa J; Ichikawa A; Iohara D; Hirayama F; Higaki K; Ohno K; Matsuo M; Irie T
    Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30845767
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Maternal immune activation modifies the course of Niemann-pick disease, type C1 in a gender specific manner.
    Cougnoux A; Fellmeth M; Gu T; Davidson CD; Gibson AL; Pavan WJ; Porter FD
    Mol Genet Metab; 2020 Feb; 129(2):165-170. PubMed ID: 31668555
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Characterization of liver disease and lipid metabolism in the Niemann-Pick C1 mouse.
    Garver WS; Jelinek D; Oyarzo JN; Flynn J; Zuckerman M; Krishnan K; Chung BH; Heidenreich RA
    J Cell Biochem; 2007 May; 101(2):498-516. PubMed ID: 17216601
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Adenosine A2A receptor modulates neuroimmune function through Th17/retinoid-related orphan receptor gamma t (RORγt) signaling in a BTBR T
    Ansari MA; Nadeem A; Attia SM; Bakheet SA; Raish M; Ahmad SF
    Cell Signal; 2017 Aug; 36():14-24. PubMed ID: 28438638
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Increased Regenerative Capacity of the Olfactory Epithelium in Niemann-Pick Disease Type C1.
    Meyer A; Wree A; Günther R; Holzmann C; Schmitt O; Rolfs A; Witt M
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28383485
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Tamoxifen and vitamin E treatments delay symptoms in the mouse model of Niemann-Pick C.
    Bascuñan-Castillo EC; Erickson RP; Howison CM; Hunter RJ; Heidenreich RH; Hicks C; Trouard TP; Gillies RJ
    J Appl Genet; 2004; 45(4):461-7. PubMed ID: 15523158
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Differential Proteomics Reveals miR-155 as a Novel Indicator of Liver and Spleen Pathology in the Symptomatic Niemann-Pick Disease, Type C1 Mouse Model.
    Pergande MR; Cougnoux A; Rathnayake RAC; Porter FD; Cologna SM
    Molecules; 2019 Mar; 24(5):. PubMed ID: 30870990
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Chronic administration of an HDAC inhibitor treats both neurological and systemic Niemann-Pick type C disease in a mouse model.
    Alam MS; Getz M; Haldar K
    Sci Transl Med; 2016 Feb; 8(326):326ra23. PubMed ID: 26888431
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Expression of Niemann-Pick type C transcript in rodent cerebellum in vivo and in vitro.
    Falk T; Garver WS; Erickson RP; Wilson JM; Yool AJ
    Brain Res; 1999 Aug; 839(1):49-57. PubMed ID: 10482798
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Lipidomic Analysis Reveals Altered Fatty Acid Metabolism in the Liver of the Symptomatic Niemann-Pick, Type C1 Mouse Model.
    Pergande MR; Serna-Perez F; Mohsin SB; Hanek J; Cologna SM
    Proteomics; 2019 Sep; 19(18):e1800285. PubMed ID: 31394590
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Hepatic Primary and Secondary Cholesterol Deposition and Damage in Niemann-Pick Disease.
    Bosch M; Fajardo A; Alcalá-Vida R; Fernández-Vidal A; Tebar F; Enrich C; Cardellach F; Pérez-Navarro E; Pol A
    Am J Pathol; 2016 Mar; 186(3):517-23. PubMed ID: 26784526
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Hearing loss is an early consequence of Npc1 gene deletion in the mouse model of Niemann-Pick disease, type C.
    King KA; Gordon-Salant S; Pawlowski KS; Taylor AM; Griffith AJ; Houser A; Kurima K; Wassif CA; Wright CG; Porter FD; Repa JJ; Brewer CC
    J Assoc Res Otolaryngol; 2014 Aug; 15(4):529-41. PubMed ID: 24839095
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Necroptosis in Niemann-Pick disease, type C1: a potential therapeutic target.
    Cougnoux A; Cluzeau C; Mitra S; Li R; Williams I; Burkert K; Xu X; Wassif CA; Zheng W; Porter FD
    Cell Death Dis; 2016 Mar; 7(3):e2147. PubMed ID: 26986514
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The proteasome inhibitor bortezomib reduced cholesterol accumulation in fibroblasts from Niemann-Pick type C patients carrying missense mutations.
    Macías-Vidal J; Girós M; Guerrero M; Gascón P; Serratosa J; Bachs O; Coll MJ
    FEBS J; 2014 Oct; 281(19):4450-66. PubMed ID: 25131710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.